Accessibility: Skip TopNav
Qualigen Therapeutics, Inc.
F3-8-60 is active in vivo against pancreatic cancer models
Format
PNG
Source
Qualigen Therapeutics, Inc.
Downloads
Original
Large
Medium
Small